Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration

[1]  Aldo Quattrone,et al.  Diffusion tensor MRI changes in gray structures of the frontal-subcortical circuits in amyotrophic lateral sclerosis , 2014, Neurological Sciences.

[2]  Steen Moeller,et al.  Advances in diffusion MRI acquisition and processing in the Human Connectome Project , 2013, NeuroImage.

[3]  Carlo Caltagirone,et al.  Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study , 2013, PloS one.

[4]  Sébastien Ourselin,et al.  STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation , 2013, Medical Image Anal..

[5]  Kawin Setsompop,et al.  Ultra-fast MRI of the human brain with simultaneous multi-slice imaging. , 2013, Journal of magnetic resonance.

[6]  C. Rowe,et al.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.

[7]  R. Katz,et al.  Regulatory innovation and drug development for early-stage Alzheimer's disease. , 2013, The New England journal of medicine.

[8]  Nick C Fox,et al.  Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease , 2013, Brain : a journal of neurology.

[9]  Paul M. Matthews,et al.  Brain Microstructure Reveals Early Abnormalities more than Two Years prior to Clinical Progression from Mild Cognitive Impairment to Alzheimer's Disease , 2013, The Journal of Neuroscience.

[10]  Jelle Jolles,et al.  Decreased gray matter diffusivity: A potential early Alzheimer’s disease biomarker? , 2013, Alzheimer's & Dementia.

[11]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[12]  K. Blennow,et al.  Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. , 2012, Archives of neurology.

[13]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[14]  E. Siemers,et al.  Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease , 2012, Alzheimer's & Dementia.

[15]  Nick C. Fox,et al.  Biomarkers for Alzheimer's disease therapeutic trials , 2011, Progress in Neurobiology.

[16]  C. Jack,et al.  Diffusion tensor imaging and cognitive function in older adults with no dementia , 2011, Neurology.

[17]  Chengjie Xiong,et al.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease , 2011, Alzheimer's Research & Therapy.

[18]  Igor Yakushev,et al.  Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[19]  Nick C Fox,et al.  Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. , 2011, Brain : a journal of neurology.

[20]  Gyógyszerészet.  National Hospital for Neurology and Neurosurgery , 2011 .

[21]  Massimo Filippi,et al.  A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[23]  Beatriz Bosch,et al.  Increased Cortical Thickness and Caudate Volume Precede Atrophy in Psen1 Mutation Carriers , 2010, Alzheimer's & Dementia.

[24]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[25]  Anders M. Fjell,et al.  Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal–parietal memory network , 2009, NeuroImage.

[26]  J. Morris,et al.  The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.

[27]  Akram Bakkour,et al.  The cortical signature of prodromal AD Regional thinning predicts mild AD dementia , 2009 .

[28]  C. Jack,et al.  β‐amyloid burden is not associated with rates of brain atrophy , 2008, Annals of neurology.

[29]  S. Rose,et al.  Gray and white matter changes in Alzheimer's disease: A diffusion tensor imaging study , 2008, Journal of magnetic resonance imaging : JMRI.

[30]  George Bartzokis,et al.  Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.

[31]  Peter Stoeter,et al.  Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI , 2007, Neurobiology of Aging.

[32]  S. Nougaret,et al.  [Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease]. , 2007, Journal of neuroradiology. Journal de neuroradiologie.

[33]  Nick C Fox,et al.  Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.

[34]  Keith A. Johnson,et al.  P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees , 2006, Alzheimer's & Dementia.

[35]  Matthias J. Müller,et al.  Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus , 2006, Psychiatry Research: Neuroimaging.

[36]  P. Stoeter,et al.  Distribution characteristics, reproducibility, and precision of region of interest-based hippocampal diffusion tensor imaging measures. , 2006, AJNR. American journal of neuroradiology.

[37]  Eric M Reiman,et al.  The Role of Biomarkers in Clinical Trials for Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[38]  Peter Stoeter,et al.  Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.

[39]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[40]  Yaniv Assaf,et al.  Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain , 2005, NeuroImage.

[41]  C. Jack,et al.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment , 2005, Neurology.

[42]  C. Van Petten,et al.  Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. , 2004, Neuropsychologia.

[43]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[44]  Takashi Inoue,et al.  Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging , 2002, Neuroscience Letters.

[45]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[46]  Massimo Filippi,et al.  Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.

[47]  Stefan Skare,et al.  A Model-Based Method for Retrospective Correction of Geometric Distortions in Diffusion-Weighted EPI , 2002, NeuroImage.

[48]  James C. Gee,et al.  Spatial transformations of diffusion tensor magnetic resonance images , 2001, IEEE Transactions on Medical Imaging.

[49]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[50]  D. Larkman,et al.  Use of multicoil arrays for separation of signal from multiple slices simultaneously excited , 2001, Journal of magnetic resonance imaging : JMRI.

[51]  D. F. Moore,et al.  Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. , 1999, AJNR. American journal of neuroradiology.

[52]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[53]  H. Braak,et al.  Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[54]  Nick C Fox,et al.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.

[55]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.